Toyoda Gosei Co., Ltd. (TGOSF)

Revance Therapeutics Revenue

Toyoda Gosei had revenue of 260.42B JPY in the quarter ending June 30, 2025, a decrease of -1.48%. This brings the company's revenue in the last twelve months to 1.06T, down -1.88% year-over-year. In the fiscal year ending March 31, 2025, Toyoda Gosei had annual revenue of 1.06T, down -1.06%.

• Revenue (ttm): 1,055.88B JPY
• Revenue Growth: -1.88%
• P/S Ratio: 0.41
• Revenue / Employee: 26.94M JPY
• Employees: 39,192
• Market Cap: 3.01B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1,059.80B	-11.31B	-1.06%
Mar 31, 2024	1,071.11B	119.23B	12.53%
Mar 31, 2023	951.88B	121.63B	14.65%
Mar 31, 2022	830.24B	108.75B	15.07%
Mar 31, 2021	721.50B	-91.44B	-11.25%